ASP Isotopes Inc.

ASP Isotopes Inc.

2.08
USD
+0.36
(+20.64%)
-1.29EPS
809.52MMarket Cap
Dec 02Next Earn
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
0.01
0.07
0.29
0.29
Basic EPS, GAAP
- -
-0.18
-0.49
-0.58
-2.11
-1.24
Free Cash Flow per Basic Share
- -
-0.28
-0.23
-0.5
-0.57
-0.78
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
0.19
0.27
0.33
0.66
1.83
2.03
Tangible Book Value per Share
0.19
0.27
0.27
0.62
1.74
1.98
Basic Weighted Avg Shares
34
27
33
56
83
106
Sales/Revenue/Turnover
- -
- -
- -
4
24
31
Operating Margin (%)
- -
- -
-3,704.63
-635.96
-239.8
-312.31
Depreciation Expense
- -
- -
- -
- -
2
5
Net Income, GAAP
- -
-5
-16
-32
-175
-132
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-3,761.03
-780.26
-734.17
-428
Working Capital
3
1
5
59
367
202
LT Debt
1
1
1
36
202
214
Total Equity
6
10
19
51
263
275
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-62.54
-124.73
-100.74
-138.93
-91.09

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
14
54
56
LT Borrowings
201
205
209
LT Finance Leases
2
3
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
112
126
130
Market Capitalization
597
556
810

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
400
309
272
Cash, Cash Equivalents & STI
333
291
255
Accounts Receivable, Net
18
2
3
Inventories
1
1
2
Total Current Liabilities
33
70
70
Payables & Accruals
16
15
14
ST Debt
14
54
56
Deferred Revenue
1
1
1

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
413.8%
Free Cash Flow
- -
- -
69%
Net Income, GAAP
- -
- -
441.51%
Sales/Revenue/Turnover
- -
- -
475.51%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1
1
1
1
4
2025
1
1
5
17
24
2026
4
5
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.16
-0.24
-0.12
-0.13
-0.58
2025
-0.12
-1.03
-0.15
-0.84
-2.11
2026
-0.06
-0.27
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Paul E. Mann
Full Time Employees
271
Sector
Industrial services
Industry
Engineering & construction
Address
2200 Ross Avenue Dallas TX United States 75201
IPO Date
Nov 10, 2022
Business
ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

Company News

  • ASP Isotopes Targets $300M EBITDA as Helium, Silicon-28 and Radiopharmacy Plans Advance

  • ASP Isotopes Inc. Announces that Renergen Limited's Virginia Gas Project has Achieved Stable Liquid Helium Production

  • Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa

  • ASP Isotopes (NASDAQ:ASPI) Director Robert John Andrew Ryan Acquires 15,000 Shares of Stock

  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript

  • ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update

  • BlackRock Inc. Purchases Shares of 9,217,198 ASP Isotopes Inc. $ASPI

  • ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth

  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa

  • Presenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live stream

  • ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia

  • ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

  • ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed

  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa

  • ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference

  • Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progress

  • ASP Isotopes Issues Letter to Shareholders

  • ASP Isotopes to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026